Drugs / Barusiban
Trials 3 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01723982 | Nov 2012 → Oct 2014 | infertility disorder | Ferring Pharmaceuticals | Completed | No outcome recorded |
| Phase 2 | NCT01043120 | Feb → May 2010 | — | Ferring Pharmaceuticals | Completed | No outcome recorded |
| Phase 2 | NCT00587327 | Nov 2007 → May 2008 | — | Ferring Pharmaceuticals | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Barusiban | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01723982 ↗ |
| Known as | FE 200440 | “Barusiban (FE 200440) Solution for Injection for Subcutaneous use” NCT01723982 ↗ |
| Action | Inhibit | “selective oxytocin antagonist (barusiban)” NCT00587327 ↗ |
| Route | Intravenous | “Solution for IV treatment.” NCT00587327 ↗ |